DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR VIRAMUNE XR

« Back to Dashboard

All Clinical Trials for Viramune Xr

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002166	An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease	Completed	Boehringer Ingelheim	Phase 3	1969-12-31	To provide access to Viramune and to evaluate the tolerance and safety of Viramune in patients with progressive, symptomatic HIV disease who failed or are intolerant to currently approved treatment for HIV-1 infection and who are unable to participate in another Viramune controlled clinical trial and have a compelling need for anti-HIV treatment.
NCT00002194	An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.	Completed	Boehringer Ingelheim	Phase 1	1969-12-31	To evaluate the potential pharmacokinetic interaction between nevirapine and clarithromycin, and to determine the effects of nevirapine on cytochrome P450 3A4 (CYP3A4) activity in vivo.
NCT00002368	The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs	Completed	Boehringer Ingelheim	Phase 3	1969-12-31	To evaluate the tolerance, safety, and effectiveness of Viramune in preventing clinical AIDS progression events or death when used in combination with Lamivudine and background nucleoside therapy.

Clinical Trial Conditions for Viramune Xr

Condition Name

Condition Name for Viramune Xr
Intervention	Trials
HIV Infections	25
Hepatic Insufficiency	2
Healthy	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Viramune Xr
Intervention	Trials
HIV Infections	27
Acquired Immunodeficiency Syndrome	6
Hepatic Insufficiency	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Viramune Xr

Trials by Country

Trials by Country for Viramune Xr
Location	Trials
United States	55
Canada	4
United Kingdom	4
Brazil	4
Argentina	3

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Viramune Xr
Location	Trials
California	6
New York	4
Rhode Island	4
Texas	3
Missouri	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Viramune Xr

Clinical Trial Phase

Clinical Trial Phase for Viramune Xr
Clinical Trial Phase	Trials
Phase 4	12
Phase 3	4
Phase 2/Phase 3	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Viramune Xr
Clinical Trial Phase	Trials
Completed	31
Terminated	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Viramune Xr

Sponsor Name

Sponsor Name for Viramune Xr
Sponsor	Trials
Boehringer Ingelheim	26
Abbott	2
Makerere University	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Viramune Xr
Sponsor	Trials
Industry	31
Other	13
NIH	4

Export unavailable in trial.
Subscribe for complete access.